A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study
Davide Ferrari(University of Modena and Reggio Emilia), Hamid Hasson(Vita-Salute San Raffaele University), Sabrina Bagaglio(Vita-Salute San Raffaele University), Simone Premaschi, Michele Raso, Giulia Morsica(Vita-Salute San Raffaele University), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Emanuela Messina(Vita-Salute San Raffaele University), Massimo Locatelli, Laura Galli(Vita-Salute San Raffaele University)
Cited by 28
Related Papers
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168